Investors in Diversity 

Rosemont Pharmaceuticals has successfully achieved the Investors in Diversity Silver Accreditation.

The liquid pharmaceutical specialists based in the UK have been working closely with Investors in Diversity to earn this important standard that sets out a framework for ensuring fairness and a sense of belonging in the workplace.

The organisation sets out a framework (FREDIE) which aims to improve fairness, respect, equality, diversity, inclusion, and engagement within the workplace. A key goal of pursuing this award is to engage employees in the values of Rosemont and recognise that everyone has a voice in the continual improvement of the employee experience. We are delighted with this testament to Rosemont’s passion for creating a diverse and inclusive environment for their employees, that they have been able to achieve this accreditation.  Rosemont will continue to be supported by Investors in Diversity on this journey and will be using insights from the FREDIE plan to shape our future plans.

 

ROS000083, DOP June 2024